Home
Company
Pipeline
Team
Media
Contact
Mais...
FAPESP
Science SP | Startup develops therapeutic vaccine for diseases caused by HPV
VivaTech | ImunoTera presents therapeutic vaccine for HPV diseases in Paris
ImunoTera: therapeutic vaccine for diseases caused by HPV
Technology will be presented during the VivaTech fair in Paris
O GLOBO
Brazilian startups enter the global biotechnology radar ImunoTera participated in the main stage of the BIO Convention 2023, in Boston (USA)
AC CAMARGO
Watch the video of the José Eduardo Ermírio de Moraes award ceremony - 2022 Our CEO received the award for ImunoTera in the category “Scientific initiatives with entrepreneurial potential”.
Meet the winners of the 1st José Eduardo Ermírio de Moraes Award: Innovations for Life
Época Negócios
ImunoTera is selected for the Albert Einstein biotechnology incubation program.
Saúde Brasília
Therapeutic vaccine against cervical cancer developed by USP presents good results in preclinical tests.
Veja
USP develops vaccine against the virus that causes cancer cervix
Sebrae
Startup participating in the Sebrae-SP program wins innovation award
USP Journal
Women scientists undertake to develop cancer immunotherapy.
BIOMINAS
ImunoTera: an unprecedented biotechnological platform in the fight against cancer.
ICB/USP
Startup creator of immunotherapy for cancer wins the Innovative Women Program.
Companies born at ICB-USP operate in biosafety, diagnostics and new cancer therapies.
Finep
Finep releases preliminary results of the second stage of the Innovative Women Program
%2014.jpg)
